Despite the increasing use of early invasive strategies in non-ST-elevation acute coronary syndromes (NSTE-ACS), optimal initial antithrombotic therapy (ATT) based on the safety/efficacy profile of all guideline-recommended combinations remains crucial for the early management of both medically and invasively treated NSTE-ACS patients.
Antithrombotic therapy in the early phase of NSTE-ACS: a systematic review and meta-analysis
Vergallo, Rocco;Ameri, Pietro;Porto, Italo;
2019-01-01
Abstract
Despite the increasing use of early invasive strategies in non-ST-elevation acute coronary syndromes (NSTE-ACS), optimal initial antithrombotic therapy (ATT) based on the safety/efficacy profile of all guideline-recommended combinations remains crucial for the early management of both medically and invasively treated NSTE-ACS patients.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
pvz031.pdf
accesso chiuso
Tipologia:
Documento in versione editoriale
Dimensione
830 kB
Formato
Adobe PDF
|
830 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
